Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1994 Jun;87(6):320–322. doi: 10.1177/014107689408700607

The extent of vitamin K deficiency in patients with cholestatic jaundice: a preliminary communication.

D P O'Brien 1, M J Shearer 1, R P Waldron 1, P G Horgan 1, H F Given 1
PMCID: PMC1294558  PMID: 8046700

Abstract

Eleven patients with cholestatic jaundice had measurements of plasma vitamin K1 performed. Seven of these 11 (64%) had subnormal levels. The prothrombin time (PT) was prolonged in three of 15 patients with cholestasis (20%), the patient with the longest PT had the lowest vitamin K1 level. A single intramuscular (im) dose of 10 mg vitamin K1 lowered the PT in 9/15 patients (includes correcting the three prolonged PTs). The initial mean plasma vitamin K1 level rose 24 h later, to a mean plasma level which was 33 times the upper limit of the normal physiological range. These preliminary results suggest that a majority of patients presenting with cholestatic jaundice have low tissue reserves of vitamin K1, and that guidelines for vitamin K1 therapy in patients with cholestatic jaundice should be revised.

Full text

PDF
320

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansell J. E., Kumar R., Deykin D. The spectrum of vitamin K deficiency. JAMA. 1977 Jul 4;238(1):40–42. [PubMed] [Google Scholar]
  2. Barkhan P., Shearer M. J. Metabolism of vitamin K1 (phylloquinone) in man. Proc R Soc Med. 1977 Feb;70(2):93–96. doi: 10.1177/003591577707000211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Frick P. G., Riedler G., Brögli H. Dose response and minimal daily requirement for vitamin K in man. J Appl Physiol. 1967 Sep;23(3):387–389. doi: 10.1152/jappl.1967.23.3.387. [DOI] [PubMed] [Google Scholar]
  4. Ham J. M. Hypoprothrombinaemia in patients undergoing prolonged intensive care. Med J Aust. 1971 Oct 2;2(14):716–718. doi: 10.5694/j.1326-5377.1971.tb92503.x. [DOI] [PubMed] [Google Scholar]
  5. Hands L. J., Royle G. T., Kettlewell M. G. Vitamin K requirements in patients receiving total parenteral nutrition. Br J Surg. 1985 Aug;72(8):665–667. doi: 10.1002/bjs.1800720828. [DOI] [PubMed] [Google Scholar]
  6. Klippel A. P., Pitsinger B. Hypoprothrombinemia secondary to antibiotic therapy and manifested by massive gastrointestinal hemorrhage. Report of three codes. Arch Surg. 1968 Feb;96(2):266–268. doi: 10.1001/archsurg.1968.01330200104020. [DOI] [PubMed] [Google Scholar]
  7. Krasinski S. D., Russell R. M., Furie B. C., Kruger S. F., Jacques P. F., Furie B. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr. 1985 Mar;41(3):639–643. doi: 10.1093/ajcn/41.3.639. [DOI] [PubMed] [Google Scholar]
  8. Lipsky J. J. Antibiotic-associated hypoprothrombinaemia. J Antimicrob Chemother. 1988 Mar;21(3):281–300. doi: 10.1093/jac/21.3.281. [DOI] [PubMed] [Google Scholar]
  9. Pineo G. F., Gallus A. S., Hirsh J. Unexpected vitamin K deficiency in hospitalized patients. Can Med Assoc J. 1973 Nov 3;109(9):880–883. [PMC free article] [PubMed] [Google Scholar]
  10. Shearer M. J., Mallinson C. N., Webster G. R., Barkhan P. Clearance from plasma and excretion in urine, faeces and bile of an intravenous dose of tritiated vitamin K 1 in man. Br J Haematol. 1972 May;22(5):579–588. doi: 10.1111/j.1365-2141.1972.tb05704.x. [DOI] [PubMed] [Google Scholar]
  11. Shearer M. J. Vitamin K metabolism and nutriture. Blood Rev. 1992 Jun;6(2):92–104. doi: 10.1016/0268-960x(92)90011-e. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES